ZA925686B - Use of 1,4-dihydropyridines in diabetes - Google Patents

Use of 1,4-dihydropyridines in diabetes

Info

Publication number
ZA925686B
ZA925686B ZA925686A ZA925686A ZA925686B ZA 925686 B ZA925686 B ZA 925686B ZA 925686 A ZA925686 A ZA 925686A ZA 925686 A ZA925686 A ZA 925686A ZA 925686 B ZA925686 B ZA 925686B
Authority
ZA
South Africa
Prior art keywords
dihydropyridines
diabetes
nimodipine
medicament
calcium
Prior art date
Application number
ZA925686A
Inventor
Joerg Traber
Traber Joerg
Willem Hendrik Gispen
Hendrik Gispen Willem
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of ZA925686B publication Critical patent/ZA925686B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the use of 1,4-dihydropyridines with a calcium-antagonistic action, especially of nimodipine, for the preparation of a medicament for controlling damage to peripheral nerves caused by diabetes.
ZA925686A 1991-07-30 1992-07-29 Use of 1,4-dihydropyridines in diabetes ZA925686B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125116A DE4125116A1 (en) 1991-07-30 1991-07-30 USE OF 1,4-DIHYDROPYRIDINE IN DIABETES

Publications (1)

Publication Number Publication Date
ZA925686B true ZA925686B (en) 1993-04-28

Family

ID=6437256

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925686A ZA925686B (en) 1991-07-30 1992-07-29 Use of 1,4-dihydropyridines in diabetes

Country Status (19)

Country Link
EP (1) EP0525537B1 (en)
JP (1) JP3381198B2 (en)
KR (1) KR930001908A (en)
AT (1) ATE111732T1 (en)
AU (1) AU659177B2 (en)
CA (1) CA2074709A1 (en)
CZ (1) CZ281712B6 (en)
DE (2) DE4125116A1 (en)
DK (1) DK0525537T3 (en)
ES (1) ES2059181T3 (en)
HU (1) HU208632B (en)
IE (1) IE65109B1 (en)
IL (1) IL102648A (en)
MX (1) MX9204423A (en)
NO (1) NO300253B1 (en)
RU (1) RU2043102C1 (en)
SK (1) SK238692A3 (en)
TW (1) TW202388B (en)
ZA (1) ZA925686B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863360A (en) * 1988-01-15 1989-09-05 Rogers Industrial Products Bag control mechanism for tire press

Also Published As

Publication number Publication date
CZ281712B6 (en) 1996-12-11
NO922795D0 (en) 1992-07-15
EP0525537A1 (en) 1993-02-03
AU659177B2 (en) 1995-05-11
NO922795L (en) 1993-02-01
IE65109B1 (en) 1995-10-04
IL102648A (en) 1997-03-18
HUT63330A (en) 1993-08-30
JPH06157314A (en) 1994-06-03
MX9204423A (en) 1993-01-01
HU9202484D0 (en) 1992-10-28
TW202388B (en) 1993-03-21
JP3381198B2 (en) 2003-02-24
KR930001908A (en) 1993-02-22
HU208632B (en) 1993-12-28
NO300253B1 (en) 1997-05-05
SK238692A3 (en) 1995-11-08
CZ238692A3 (en) 1994-01-19
EP0525537B1 (en) 1994-09-21
CA2074709A1 (en) 1993-01-31
DE59200530D1 (en) 1994-10-27
DK0525537T3 (en) 1995-02-20
IL102648A0 (en) 1993-01-14
ES2059181T3 (en) 1994-11-01
ATE111732T1 (en) 1994-10-15
AU2048492A (en) 1993-02-04
RU2043102C1 (en) 1995-09-10
IE922467A1 (en) 1993-02-10
DE4125116A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
NZ227131A (en) Compositions for improving cognitive function by administering 1,2-oxazole derivatives
EP1607387A3 (en) 3,4,4-trisubstituted piperidine derivatives and their use as opioid antagonists
AU1760988A (en) Enhancers for the transdermal flux of certain 1,4-dihydropyridine derivatives
KR900700569A (en) 2,3-difluorobenzene derivative
HU9201013D0 (en) Piperidine derivatives
ZA916058B (en) Novel 1,4-dihydropyridine derivatives
JPS6419066A (en) Dihydropyridineamides
TW231256B (en)
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
ZA925686B (en) Use of 1,4-dihydropyridines in diabetes
EP0247345A3 (en) 1,4-dihydropyridine-3,5-dicarboxylates incorporating an alkyleneaminoalkylene-heteroatom moiety
DE69426021D1 (en) Xamonelin tartrate
AU1662092A (en) Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
AU6984987A (en) Substituted 1,4-dihydropyridine ester derivatives
GB2196631B (en) 2-substituted 1,4-dihydropyridine derivatives
GR3031294T3 (en) Optically active 1,4-Dihydropyridine derivatives and methods of producing the same
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
AU2861589A (en) 1,2,3,6/1,2,5,6-Tetrahydropyridine derivatives
EP0473543A3 (en) 1,3,2-oxazaphospholidine stabilizers
IT223912Z2 (en) ENDOOXY SCREW WITH PERFECT STRUCTURE, FOR DENTAL IMPLANTOLOGY
IT8820268A0 (en) INCREASED. ENDOOSSEOUS SCREW FOR DENTAL IMPLANTOLOGY, COMPATIBILITY
AR243881A1 (en) A procedure for the preparation of 1,4-dihydropyridine.
CS466986A1 (en) N l4 l3,6 dioxo 2,3,4,6 tetrahydro 1,2,4 benzotriazin2 y1 p benzoyl p l glutamova kyselina a zpusob jeji pripravy